313 related articles for article (PubMed ID: 19688145)
1. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
2. TGFβ/Smad signalling in psoriatic epidermis models exposed to salt water soaks and narrowband ultraviolet B radiation.
Gambichler T; Terras S; Skrygan M
Cytokine; 2013 Oct; 64(1):35-8. PubMed ID: 23838545
[TBL] [Abstract][Full Text] [Related]
3. Sequential gonadotropin treatment of immature mice leads to amplification of transforming growth factor beta action, via upregulation of receptor-type 1, Smad 2 and 4, and downregulation of Smad 6.
Guéripel X; Benahmed M; Gougeon A
Biol Reprod; 2004 Mar; 70(3):640-8. PubMed ID: 14585817
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris.
Doi H; Shibata MA; Kiyokane K; Otsuki Y
J Dermatol Sci; 2003 Oct; 33(1):7-16. PubMed ID: 14527734
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes.
Baugé C; Legendre F; Leclercq S; Elissalde JM; Pujol JP; Galéra P; Boumédiene K
Arthritis Rheum; 2007 Sep; 56(9):3020-32. PubMed ID: 17763417
[TBL] [Abstract][Full Text] [Related]
8. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
9. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
[TBL] [Abstract][Full Text] [Related]
10. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
Baker K; Raut P; Jass JR
J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
[TBL] [Abstract][Full Text] [Related]
12. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
[TBL] [Abstract][Full Text] [Related]
13. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes.
Baugé C; Attia J; Leclercq S; Pujol JP; Galéra P; Boumédiene K
Arthritis Rheum; 2008 Jan; 58(1):221-6. PubMed ID: 18163503
[TBL] [Abstract][Full Text] [Related]
15. The Smad family and its role in pancreatic cancer.
Singh P; Wig JD; Srinivasan R
Indian J Cancer; 2011; 48(3):351-60. PubMed ID: 21921337
[TBL] [Abstract][Full Text] [Related]
16. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Yu Z; Xing Y
Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs.
Alejandre-Alcázar MA; Michiels-Corsten M; Vicencio AG; Reiss I; Ryu J; de Krijger RR; Haddad GG; Tibboel D; Seeger W; Eickelberg O; Morty RE
Dev Dyn; 2008 Jan; 237(1):259-69. PubMed ID: 18095342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]